Detalle Publicación

ARTÍCULO

A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.

Autores: Soutullo Esperón, César Alejandro; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
Título de la revista: CNS DRUGS
ISSN: 1172-7047
Volumen: 27
Páginas: 743-751
Fecha de publicación: 2013
Resumen:
This post hoc analysis showed that, at the doses tested, patients treated with lisdexamfetamine showed statistically significantly greater improvement in symptoms of ADHD than those receiving OROS-MPH, as assessed using the ADHD-RS-IV and CGI-I. The safety profiles of lisdexamfetamine and OROS-MPH were consistent with the known effects of stimulant medications.
DOI: https://doi.org/10.1007/s40263-013-0086-6.
Impacto:
Google Scholar